Marathon Rotary Club

Wednesday, 12:15pm Meeting at the Marathon Yacht Club


A deadly and common side-effect of lifesaving bone marrow transplants.

Alpha-1-antitrypsin may reduce ramifications of GVHD A natural enzyme derived from human bloodstream plasma showed potential in significantly reducing the effects of graft-vs.-host disease, a deadly and common side-effect of lifesaving bone marrow transplants contact . Researchers from the University of Michigan Comprehensive Cancer Center viewed the drug alpha-1-antitrypsin, which is approved by the U.S. Food and Drug Administration for make use of in individuals who have a genetic mutation that makes them deficient in a particular enzyme. This medication has been used in many of these sufferers over extended periods of time and is known to cause minimal unwanted effects.